Page last updated: 2024-09-04

ym 872 and Infarction, Middle Cerebral Artery

ym 872 has been researched along with Infarction, Middle Cerebral Artery in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kawasaki-Yatsugi, S; Kohara, A; Ni, JW; Okada, M; Sakamoto, S; Shimizu-Sasamata, M; Shishikura, J; Takahashi, M; Yamaguchi, T; Yatsugi, S	1

Reviews

1 review(s) available for ym 872 and Infarction, Middle Cerebral Artery

Article	Year
YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist. CNS drug reviews, 2002,Winter, Volume: 8, Issue:4 Topics: Animals; Brain Ischemia; Cats; Clinical Trials, Phase I as Topic; Disease Models, Animal; Excitatory Amino Acid Antagonists; Humans; Imidazoles; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Quinoxalines; Rats; Receptors, AMPA; Solubility; Stroke	2002

Article

Year

YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.

CNS drug reviews, 2002,Winter, Volume: 8, Issue:4

Topics: Animals; Brain Ischemia; Cats; Clinical Trials, Phase I as Topic; Disease Models, Animal; Excitatory Amino Acid Antagonists; Humans; Imidazoles; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Quinoxalines; Rats; Receptors, AMPA; Solubility; Stroke

2002